LWAC
CVS icon

Laurel Wealth Advisors (California)’s CVS Health CVS Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.55M Sell
16,679
-166
-1% -$16K 0.15% 149
2022
Q3 		$1.61M Sell
16,845
-1,918
-10% -$190K 0.17% 133
2022
Q2 		$1.74M Buy
18,763
+1,211
+7% +$118K 0.18% 129
2022
Q1 		$1.78M Sell
17,552
-1,020
-5% -$107K 0.15% 154
2021
Q4 		$1.92M Buy
18,572
+13,266
+250% +$1.23M 0.15% 140
2021
Q3 		$450K Sell
5,306
-926
-15% -$77.6K 0.08% 254
2021
Q2 		$520K Sell
6,232
-638
-9% -$52.2K 0.07% 264
2021
Q1 		$517K Buy
6,870
+1,790
+35% +$130K 0.08% 248
2020
Q4 		$347K Sell
5,080
-804
-14% -$52.3K 0.05% 309
2020
Q3 		$344K Sell
5,884
-113
-2% -$7.03K 0.06% 279
2020
Q2 		$390K Sell
5,997
-7,516
-56% -$473K 0.07% 249
2020
Q1 		$802K Buy
13,513
+6,788
+101% +$453K 0.18% 136
2019
Q4 		$500K Sell
6,725
-166
-2% -$11.7K 0.08% 252
2019
Q3 		$435K Buy
6,891
+1,704
+33% +$101K 0.07% 280
2019
Q2 		$283K Sell
5,187
-390
-7% -$21K 0.06% 318
2019
Q1 		$301K Sell
5,577
-1,857
-25% -$115K 0.07% 285
2018
Q4 		$487K Sell
7,434
-99
-1% -$7.39K 0.14% 165
2018
Q3 		$592K Sell
7,533
-254
-3% -$18.2K 0.15% 154
2018
Q2 		$501K Buy
7,787
+1,044
+15% +$68.8K 0.13% 175
2018
Q1 		$419K Buy
6,743
+1,352
+25% +$97K 0.13% 191
2017
Q4 		$390K Buy
5,391
+1,842
+52% +$134K 0.11% 209
2017
Q3 		$288K Sell
3,549
-1,083
-23% -$85.7K 0.1% 225
2017
Q2 		$372K Sell
4,632
-561
-11% -$44.3K 0.13% 182
2017
Q1 		$407K Buy
5,193
+857
+20% +$68.4K 0.16% 163
2016
Q4 		$342K Sell
4,336
-412
-9% -$33.3K 0.15% 164
2016
Q3 		$423K Buy
4,748
+108
+2% +$10.2K 0.2% 131
2016
Q2 		$444K Buy
4,640
+1,235
+36% +$123K 0.21% 120
2016
Q1 		$353K Sell
3,405
-153
-4% -$14.9K 0.18% 145
2015
Q4 		$348K Buy
+3,558
New +$348K 0.18% 154

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Laurel Wealth Advisors (California)'s CVS Position: Q4 2022 in Review

Laurel Wealth Advisors (California) reduced its CVS Health (CVS) stake by 0.99% in Q4 2022, selling an estimated $16K and leaving 16,679 shares worth $1.55M. The position accounts for 0.15% of the portfolio, ranked #149.

Laurel Wealth Advisors (California) first reported a position in CVS in Q4 2015 and has held it in 29 quarters since. The position peaked at $1.92M in Q4 2021. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Laurel Wealth Advisors (California) held 16,679 shares of CVS Health worth $1.55M as of Q4 2022.
  • Laurel Wealth Advisors (California) sold 166 CVS Health shares in Q4 2022, an estimated $16K.
  • CVS Health made up 0.15% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #149 holding.
  • Laurel Wealth Advisors (California) first reported a position in CVS Health in Q4 2015 and has held it in 29 quarters since.
  • Laurel Wealth Advisors (California)'s CVS Health position peaked at $1.92M in Q4 2021.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.